Evaluation of an Oral Contraceptive Containing 30 mg Ethinyloestradiol and 150 mg Desogestrel on Women's Health

NCT01256619 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Women With PMS

Interventions

DRUG: Marvelon

Sponsor

Tehran University of Medical Sciences